• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

    3/20/25 7:00:00 AM ET
    $SLP
    EDP Services
    Technology
    Get the next $SLP alert in real time by email

    Conference call to be on Thursday, April 3, 2025, at 5 p.m. ET

    Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it will report second quarter fiscal 2025 financial results after the market close on Thursday, April 3, 2025.

    Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.

    About Simulations Plus, Inc.

    With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.

    Environmental, Social, and Governance (ESG)

    We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250320267438/en/

    Financial Profiles

    Lisa Fortuna

    310-622-8251

    [email protected]

    Get the next $SLP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SLP

    DatePrice TargetRatingAnalyst
    12/18/2025Buy → Neutral
    BTIG Research
    9/30/2025$16.00Hold
    TD Cowen
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/15/2024$39.00Overweight
    Stephens
    7/29/2024$47.00Overweight
    KeyBanc Capital Markets
    7/16/2024Mkt Perform
    JMP Securities
    6/28/2024Outperform
    William Blair
    5/9/2023$55.00Buy
    BTIG Research
    More analyst ratings

    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

    Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025. First Quarter 2026 Financial Highlights (as compared to first quarter 2025) Total revenue decreased 3% to $18.4 million Software revenue decreased 17% to $8.9 million, representing 48% of total revenue Services revenue increased 16% to $9.5 million, representing 52% of total revenue Gross profit was $10.9 million and gross mar

    1/8/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development

    Driving Growth with Integrated Software, Services, and AI-Enabled Ecosystem Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026. The event will offer investors and analysts an in-depth look at the Company's long-term strategy, product roadmap, and financial outlook, as well as a Q&A session with the executive leadership team. "Biopharma companies are rethinking how they develop medicines—prioritizing greater predictability, transparency, and scientific rigor at every step. S

    12/18/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

    Conference call to be on Thursday, January 8, 2026, at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will report first quarter fiscal 2026 financial results after the market close on Thursday, January 8, 2026. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (in

    12/17/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Simulations Plus downgraded by BTIG Research

    BTIG Research downgraded Simulations Plus from Buy to Neutral

    12/18/25 9:02:23 AM ET
    $SLP
    EDP Services
    Technology

    TD Cowen initiated coverage on Simulations Plus with a new price target

    TD Cowen initiated coverage of Simulations Plus with a rating of Hold and set a new price target of $16.00

    9/30/25 8:58:03 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Simulations Plus from Overweight to Sector Weight

    7/15/25 8:39:07 AM ET
    $SLP
    EDP Services
    Technology

    Director Woltosz Walter S gifted 9,095 shares, decreasing direct ownership by 0.28% to 3,278,907 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    12/22/25 4:06:51 PM ET
    $SLP
    EDP Services
    Technology

    Director Lavange Lisa sold $14,644 worth of shares (866 units at $16.91), decreasing direct ownership by 8% to 9,968 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    12/2/25 4:14:15 PM ET
    $SLP
    EDP Services
    Technology

    Director Lavange Lisa was granted 1,771 shares, increasing direct ownership by 20% to 10,834 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    11/4/25 4:38:00 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    SEC Filings

    View All

    Simulations Plus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Simulations Plus, Inc. (0001023459) (Filer)

    1/8/26 4:07:50 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form DEFA14A filed by Simulations Plus Inc.

    DEFA14A - Simulations Plus, Inc. (0001023459) (Filer)

    12/29/25 4:06:26 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form DEF 14A filed by Simulations Plus Inc.

    DEF 14A - Simulations Plus, Inc. (0001023459) (Filer)

    12/29/25 4:05:51 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Financials

    Live finance-specific insights

    View All

    Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

    Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025. First Quarter 2026 Financial Highlights (as compared to first quarter 2025) Total revenue decreased 3% to $18.4 million Software revenue decreased 17% to $8.9 million, representing 48% of total revenue Services revenue increased 16% to $9.5 million, representing 52% of total revenue Gross profit was $10.9 million and gross mar

    1/8/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

    Conference call to be on Thursday, January 8, 2026, at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will report first quarter fiscal 2026 financial results after the market close on Thursday, January 8, 2026. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (in

    12/17/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

    Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10  Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software revenue decreased 9% to $9.0 million, representi

    12/1/25 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    8/8/24 2:18:03 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    2/13/24 5:13:58 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    2/12/24 4:59:04 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

    QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC ("Pro-ficiency" or the "Company"), a leader in providing tech-enabled training and compliance solutions for clinical trial investigators and site staff, to Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy. Michael Raymer, Chief Executive Officer of Pro-ficiency, said, "We are excited to join the Simulations Plus team, which has a well-established and recognized leadership position in modeling and simulations wi

    6/12/24 8:58:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

    LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today the appointment of Will Frederick as chief financial officer (CFO), succeeding John Kneisel, who retires after seven years with the company. Will Frederick brings more than 25 years of financial leadership experience to the company. He has a proven track record of developing and implementing strategies to drive revenue growth, increase profitability, managing merger & acquisition activities and achieving corporate objectives. He has global experience with both publicly traded and privately held companies including Pharsight, Entelos, Avaya, The Walt Disney Company and Ford Motor Company, among

    12/1/20 4:05:00 PM ET
    $DIS
    $SLP
    $F
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    EDP Services
    Technology